This book dives into the financial side of cancer treatment, focusing on immunotherapy. It analyzes costs of new treatments, comparing them to traditional methods.Chapter 1 gives an economic overview of cancer immunotherapy, including cost analyses, funding, and global impact. Chapter 2 explores checkpoint inhibitor pricing and financial aid models. Chapter 3 breaks down CAR T-cell therapy expenses, while Chapter 4 examines cancer vaccine development costs.Chapters 5-11 cover various immunotherapies, discussing development ...
Read More
This book dives into the financial side of cancer treatment, focusing on immunotherapy. It analyzes costs of new treatments, comparing them to traditional methods.Chapter 1 gives an economic overview of cancer immunotherapy, including cost analyses, funding, and global impact. Chapter 2 explores checkpoint inhibitor pricing and financial aid models. Chapter 3 breaks down CAR T-cell therapy expenses, while Chapter 4 examines cancer vaccine development costs.Chapters 5-11 cover various immunotherapies, discussing development costs, market adoption, and financial policies. Chapter 12 proposes strategies to lower costs and improve global access.Essential reading for healthcare financiers, policymakers, and those involved in cancer treatment, this book provides key insights into the financial implications of advanced cancer therapies.
Read Less
Add this copy of Finance of Fighting Cancer to cart. $67.40, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2025 by Scholars' Press.
Add this copy of Finance of Fighting Cancer: Costs, Access, Impact to cart. $76.14, new condition, Sold by Just one more Chapter rated 3.0 out of 5 stars, ships from Miramar, FL, UNITED STATES, published 2025 by Scholars' Press.
